❄️ Myxedema Coma

πŸ” Definition:

Myxedema coma is a life-threatening complication of severe hypothyroidism, characterized by:

  • Decompensated metabolic state
  • Hypothermia, bradycardia, hypotension
  • Altered mental status, and often multi-organ failure

Despite the name, coma is not always present β€” altered sensorium may vary from confusion to stupor to coma.


⚠️ Why It Matters in ICU:

  • Rare but high mortality (30–60%)
  • Often misdiagnosed as sepsis, stroke, or hypothermia
  • Requires early recognition and aggressive therapy


🧬 Pathophysiology:

  1. Severe deficiency of T3 and T4:
    • ↓ cellular metabolism
    • ↓ thermogenesis
    • ↓ adrenergic tone
  1. Multi-organ hypofunction:
    • Cardiovascular: ↓ HR, ↓ CO β†’ shock
    • CNS: ↓ perfusion β†’ coma
    • Kidneys: ↓ GFR β†’ hyponatremia
    • Lungs: hypoventilation β†’ COβ‚‚ retention


🧨 Precipitating Factors:

Common Triggers

Examples

Infections

Pneumonia, UTI, sepsis

Cold exposure

Especially in elderly

Drugs

Sedatives, narcotics, amiodarone, lithium

Withdrawal of thyroid meds

Poor compliance, post-radioiodine therapy

Surgery / Trauma

Stressors in untreated hypothyroid patients



🩺 Clinical Features:

System

Symptoms / Signs

CNS

Confusion, lethargy, coma, seizures

CVS

Bradycardia, hypotension, cardiogenic shock

Respiratory

Hypoventilation, COβ‚‚ retention, hypoxia

GI

Ileus, constipation, decreased bowel sounds

Renal

↓ GFR, hyponatremia, water retention

Thermal

Hypothermia (<35Β°C, sometimes <30Β°C)

Skin

Dry, cold, non-pitting edema, hair loss

Facial

Puffy face, macroglossia, hoarseness


πŸ’‘ Myxedema coma should be suspected in elderly, winter-onset, unresponsive, bradycardic, hypothermic patient.


πŸ§ͺ Laboratory Findings:

Parameter

Typical Finding

TSH

↑↑ (primary hypothyroidism)

Free T3/T4

↓↓

Na+

↓ (dilutional hyponatremia)

Glucose

↓ (hypoglycemia)

ABG

Respiratory acidosis (hypoventilation)

Cortisol

Rule out adrenal insufficiency

ECG

Bradycardia, low voltage, QT prolongation



🧠 Differential Diagnosis:

  • Sepsis
  • Stroke
  • Adrenal crisis
  • Hypothermia
  • Sedative overdose
  • Uremic encephalopathy


πŸ”Ž Diagnosis:

  • Clinical suspicion is key
  • No single diagnostic score is universally accepted, but diagnosis is made in presence of:
    • Known hypothyroidism or strong signs
    • Hypothermia
    • Altered mental status
    • Bradycardia
    • Precipitating event
    • Biochemically low T4 with high TSH


πŸ’Š Management Strategy:

🟩 1. Supportive Care

  • ICU admission, mechanical ventilation if needed
  • Warm blankets (passive rewarming only β€” avoid aggressive rewarming)
  • Vasopressors (norepinephrine) if hypotensive
  • Correct hypoglycemia, hyponatremia, acidosis

🟨 2. Thyroid Hormone Replacement

πŸ“Œ Preferred: IV levothyroxine (T4):

  • Loading dose: 200–400 mcg IV
  • Maintenance: 50–100 mcg IV daily

Optional: Add IV liothyronine (T3) (especially in coma)

  • 10–20 mcg IV, then 10 mcg q8–12h

T3 acts faster but may precipitate arrhythmias; use cautiously in elderly/CAD.

🟦 3. Glucocorticoids

  • Hydrocortisone 100 mg IV q8h
  • Given empirically until adrenal insufficiency is ruled out (due to possibility of coexistent autoimmune adrenalitis)

πŸŸ₯ 4. Treat Precipitating Cause

  • Empirical antibiotics until infection ruled out
  • Hold CNS depressants


⚠️ Avoid:

  • Overzealous rewarming β†’ vasodilation and cardiovascular collapse
  • Sedatives/narcotics
  • Inadequate dosing or oral therapy in comatose patients


πŸ“‰ Prognosis:

Factor

Impact on Prognosis

Early diagnosis

Better outcome

Advanced age

Worse prognosis

Cardiorespiratory failure

↑ Mortality

Delay in treatment

↑ Mortality (30–60%)



🧠 Mnemonic – β€œMYXEDEMA” (for features)

  • M – Mental status altered (coma/confusion)
  • Y – Yellow skin (carotenemia)
  • X – eXtreme hypothermia
  • E – Edema (non-pitting)
  • D – Depression (CNS, mood)
  • E – Electrolyte disturbances (Na+, glucose ↓)
  • M – Myopathy, bradycardia
  • A – Apnea, hypoventilation